COVID-19 Vaccine DevelopmentFurman, Richard R.Clinical Advances in Hematology & Oncology
The global vaccine effort in response to the COVID-19 pandemic is unprecedented in terms of both scale and speed. SARS-CoV-2 vaccines will be essential in reducing mortality when the virus establishes itself in the population. The race is now on for the
The milestones of COVID-19 vaccine development. With the maturity of vaccine platforms, more and more COVID-19 vaccines have entered clinical trials and been approved for emergency use in many countries. However, the appearance of VOCs has brought great challenges to existing COVID-19 vaccines. ...
Oral Tablet COVID-19 Subunit vaccine Dissolves on the tongue. No need for healthcare professionals for administration Stable at room temperature for 2 months. Simplified logistics. Protein-based formulation. Potential safety for pediatric, adolescent, pregnant populations ...
The COVID-19 pandemic has infected millions of people with no clear signs of abatement owing to the high prevalence, long incubation period and lack of established treatments or vaccines. Vaccines are the most promising solution to mitigate new viral str
BEIJING, March 26 (Xinhua) -- China has strengthened international cooperation in the research and development of vaccines against the novel coronavirus disease (COVID-19), according to an official Thursday. Vaccines are key to the fight against the epidemic and it is the right choice to carry...
Similar to the drug development landscape for COVID-19, various companies started preclinical testing to develop preventive or therapeutic vaccines. The advancements predominantly include mRNA vaccines followed by combination vaccines, genetic vaccines, and re-engineered pneumonia vaccines. Here are some of...
Covid-19 Coronavirus Pandemic Human challenge study Ethics Vaccine 1. Introduction As the world struggles to control the COVID-19 pandemic, some researchers have proposed a bold agenda: using a ‘challenge study’ to deliberately infect individuals in order to accelerate vaccine development [1]. In...
China's National Medical Products Administration (NMPA) has granted conditional market approval to CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech. It is the second domestically developed COVID-19 vaccine to receive conditional market approval in the country....
Vaccines are one of our greatest tools to protect against infectious diseases and the world waits with bated breath for a vaccine against coronavirus (COVID-19). The wait might be much shorter if we can hone new methods of vaccine development. ...